William P. Forbes, EVP Research&Devel & CDO at SALIX PHARMACEUTICALS LTD (SLXP), sold 10,000 shares at $52.26 ($516K) on 2012-05-08, disclosed to the SEC on 2012-05-21.
Scheduled sale ($516k) by EVP Research&Devel & CDO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.35 | 7,100 | $365K | 70.6% |
| 2 | $52.26 | 2,900 | $152K | 29.4% |
| Total | $51.61 avg | 10,000 | $516K | 100% |
| Filing → |
| XAIR | BUY | 2023-04-03 | $33K | — | Filing → |
| XAIR | BUY | 2023-03-20 | $32K | — | Filing → |
| XAIR | BUY | 2019-11-15 | $25K | — | Filing → |